North America Neurotoxins Market Forecast to 2028

North America Neurotoxins Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type (Botox, Dysport, Xenomin, and Others), Application (Therapeutic and Aesthetic), and End User (Hospitals, Specialty Clinics, Dermatology Clinics, and Others)

Send Enquiry
Item ID: BMIRE00028824 Category: Tags: , ,

$2,100$3,500

Description

The North America neurotoxins market is expected to grow from US$ 4,801.29 million in 2023 to US$ 8,416.95 million by 2028. It is estimated to grow at a CAGR of 11.9% from 2023 to 2028.

Emergence of Innovative Facial Aesthetic Products Fuels North America Neurotoxins Market

The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of “DTX-021″—a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world’s first pan-facial microinjection of neurotoxins. Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach’s evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus. Therefore, emergence of innovative facial aesthetic products helps the North America neurotoxin market to grow.

North America Neurotoxins Market Overview

The North America neurotoxin market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for neurotoxins. The market growth in the region is attributed to the increasing product launches, growing FDA approvals for neurotoxins for various muscular conditions, rising aging population, increasing numbers of non-surgical or minimally invasive cosmetic procedures, increasing number of aesthetic procedures, and growing demand for minimally invasive therapeutics.

North America Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)

North America Neurotoxins Market Segmentation

The North America neurotoxins market is segmented into product type, application, end user, and country. Based on product type, the North America neurotoxins market is sub segmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.

Based on application, the North America neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.

Based on end user, the North America neurotoxins market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.

Based on country, the North America neurotoxins market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.

AbbVie Inc, Hugel Inc, Ipsen SA, Medytox Inc, Merz Pharma GmbH & Co KGaA, Metabiologics, and Revance Therapeutics Inc are among the leading companies operating in the North America neurotoxins market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 11.9% CAGR, the North America Neurotoxins Market is speculated to be worth US$ 8,416.95 million by 2028, saysthe research team

According tothe research team’ research, the North America neurotoxins market was valued at US$ 4,801.29 million in 2023 and is expected to reach US$ 8,416.95 million by 2028, registering a CAGR of 11.9% from 2023 to 2028. Surge in cosmetic procedures to improve appearance and emergence of innovative facial aesthetic products are the critical factors attributed to the North America neurotoxins market expansion.

Structural changes affecting the skin, muscles, ligaments, fat, and bone get noticeable on an individual’s face due to decrease in cellular functions with aging. The inevitable physiological process of aging is generally not conceived positively by many, which, in turn, urges them to indulge in cosmetic rejuvenation procedures to remain youthful visually. Botulinum toxin naturally produced by Clostridium botulinum most popular neurotoxin used in cosmetic procedures. Therefore, the rising popularity of cosmetic procedures involving neurotoxins to reduce facial wrinkles while ensuring safety, effectivity, and efficiency is catalyzing the North America neurotoxins market.

On the contrary, improper/inappropriate injection technique hurdles the growth of North America neurotoxins market.

Based on product type, the North America neurotoxins market is segmented into botox, dysport, xenomin, and others. The botox segment held 94.1% market share in 2023, amassing US$ 4,516.21 million. It is projected to garner US$ 7,879.87 million by 2028 to expand at 11.8% CAGR during 2023–2028.

Based on application, the North America neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held 50.9% market share in 2023, amassing US$ 2,442.91 million. It is projected to garner US$ 4,255.31 million by 2028 to expand at 11.7% CAGR during 2023–2028.

Based on end user, the North America neurotoxins market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held 52.2% market share in 2023, amassing US$ 2,504.34 million. It is projected to garner US$ 4,423.60 million by 2028 to expand at 12.1% CAGR during 2023–2028.

Based on country, the North America neurotoxins market has been categorized into US, Canada, and Mexico. Our regional analysis states that US captured 85.7% market share in 2023. It was assessed at US$ 4,114.29 million in 2023 and is likely to hit US$ 7,265.51 million by 2028, exhibiting a CAGR of 12.0% during the forecast period.

Key players dominating the North America neurotoxins market are AbbVie Inc, Hugel Inc, Ipsen SA, Medytox Inc, Merz Pharma GmbH & Co KGaA, Metabiologics, Revance Therapeutics Inc among others.

In Nov-2023, AbbVie announced new results from its exploratory NOVA phase 2 dose-ranging study evaluating the efficacy and safety of AGN-151607, a novel investigational neurotoxin for preventing postoperative atrial fibrillation (POAF) in cardiac surgery patients. The results were presented at the 2023 American Heart Association Scientific Sessions in Chicago, IL, USA, during the Late-Breaking Science session titled “Treating Atrial and Supraventricular Arrhythmias”.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Neurotoxin Market – by Type
1.3.2 North America Neurotoxin Market – by Application
1.3.3 North America Neurotoxin Market – by End User
1.3.4 North America Neurotoxin Market – by Country
2. North America Neurotoxin Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Neurotoxin Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Neurotoxin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surge in Cosmetic Procedures to Improve Appearance
5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
5.2.1 Improper/Inappropriate Injection Technique
5.3 Market Opportunities
5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
5.4 Future Trends
5.4.1 BOTA for Assisted Reproductive Technology (ART)
5.5 Impact Analysis
6. North America Neurotoxin Market
6.1 North America Neurotoxin Market Revenue Forecast and Analysis
7. North America Neurotoxin Market – Revenue and Forecast to 2028 – By Type
7.1 Overview
7.2 North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
7.3.1 Overview
7.3.2 Botox: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
7.4.1 Overview
7.4.2 Dysport: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
7.5.1 Overview
7.5.2 Xeomin: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Neurotoxin Market – Revenue and Forecast to 2028 – By Application
8.1 Overview
8.2 North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
8.3.1 Overview
8.3.2 Therapeutic: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Neurotoxin Market – Revenue and Forecast to 2028 – By End User
9.1 Overview
9.2 North America Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
9.4.1 Overview
9.4.2 Medical Spas and Beauty Centers: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
9.5.1 Overview
9.5.2 Dermatology Clinics: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Neurotoxin Market –Revenue and Forecast to 2028- Country Analysis
10.1 Overview
10.1.1 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
10.1.1.1 US: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.2 Canada: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.3 Mexico: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
11. North America Neurotoxins Market–Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Merz Pharma GmbH & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AbbVie Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Revance Therapeutics Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Ipsen SA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Medytox Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Hugel Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Metabiologics
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About
13.2 Glossary of Terms

LIST OF TABLES

Table 1.             North America Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
Table 2.             US Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 3.             US Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4.             US Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5.             Canada: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 6.             Canada: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 7.             Canada: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8.             Mexico: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 9.             Mexico: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10.          Mexico: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11.          Recent Organic Growth Strategies in Neurotoxins Market
Table 12.          Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 13.          Glossary of Terms
 
 

LIST OF FIGURES

Figure 1.           North America Neurotoxin Market Segmentation
Figure 2.           North America Neurotoxin Market by Country
Figure 3.           North America Neurotoxin Market Overview
Figure 4.           North America Neurotoxin Market, By Type
Figure 5.           North America Neurotoxin Market, By Country
Figure 6.           North America: PEST Analysis
Figure 7.           North America Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 8.           North America Neurotoxin Market – Revenue Forecast and Analysis – 2021–2028
Figure 9.           North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 10.        Botox: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11.        Dysport: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12.        Xeomin: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13.        Others: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14.        North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 15.        Therapeutic: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16.        Aesthetic: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17.        North America Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 18.        Hospitals: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19.        Medical Spas and Beauty Centers: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20.        Dermatology Clinics: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21.        Others: North America Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22.        North America: Neurotoxin Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23.        North America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 24.        US: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25.        Canada: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26.        Mexico: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million) 

The List of Companies – North America Neurotoxins Market

– AbbVie Inc
– Hugel Inc
– Ipsen SA
– Medytox Inc
– Merz Pharma GmbH & Co KGaA
– Metabiologics
– Revance Therapeutics Inc

Reviews

There are no reviews yet.

Be the first to review “North America Neurotoxins Market Forecast to 2028”